BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/18/2025 5:53:46 AM | Browse: 64 | Download: 274
 |
Received |
|
2025-04-21 04:40 |
|
Peer-Review Started |
|
2025-04-21 04:40 |
|
First Decision by Editorial Office Director |
|
2025-05-12 03:45 |
|
Return for Revision |
|
2025-05-12 03:45 |
|
Revised |
|
2025-06-09 01:01 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-10 02:46 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-10 08:09 |
|
Articles in Press |
|
2025-12-10 08:09 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-12-15 15:13 |
|
Publish the Manuscript Online |
|
2025-12-18 05:53 |
| ISSN |
2308-3840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Reevaluating aminosalicylates role in maintaining remission in ulcerative colitis: Systematic review and meta-analysis in the era of biologics
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Themba Mudege and Jonathan Soldera |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jonathan Soldera, PhD, Professor, Department of Gastroenterology, University of South Wales, Llantwit Road, Pontypridd, Cardiff CF37 1DL, United Kingdom. jonathansoldera@gmail.com |
| Key Words |
Colitis ulcerative; Mesalamine; Remission induction; Biological therapy; Sulfasalazine |
| Core Tip |
Oral 5-aminosalicylic acid (5-ASA) has long been a cornerstone treatment for maintaining remission in ulcerative colitis (UC). This systematic review and meta-analysis of 44 randomized controlled trials, involving nearly 10000 patients, demonstrates that 5-ASA is significantly more effective than placebo in sustaining remission in quiescent UC, with a favorable safety profile. Despite the emergence of advanced therapies such as biologics and small molecules, 5-ASA remains a viable and cost-effective option. These findings underscore the enduring relevance of 5-ASA and highlight the need for tailored therapeutic approaches in the modern management of UC. |
| Publish Date |
2025-12-18 05:53 |
| Citation |
Mudege T, Soldera J. Reevaluating aminosalicylates role in maintaining remission in ulcerative colitis: Systematic review and meta-analysis in the era of biologics. World J Meta-Anal 2025; 13(4): 108681 |
| URL |
https://www.wjgnet.com/2308-3840/full/v13/i4/108681.htm |
| DOI |
https://dx.doi.org/10.13105/wjma.v13.i4.108681 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
